Picture of Biotika as logo

1BSL01AE Biotika as Cashflow Statement

0.000.00%
sk flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Annual cashflow statement for Biotika as, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2016
December 31st
2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.163.711.472.52.73
Depreciation
Non-Cash Items0.006-2.83-0.078-0.062-0.796
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2.05-0.57-0.34-1.4-1.17
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities2.443.283.593.392.89
Capital Expenditures-1.22-0.331-0.468-0.225-1.47
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.6433.270.810.3020.093
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-0.582.930.3430.077-1.37
Financing Cash Flow Items0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3.27-3.53-1.72-2.51-0.914
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.42.672.210.9580.589

Or unlock with your email

Or unlock with your email